bookmark

Baxter Begins Trial of Stem Cells for Angiogenesis in Coronary Artery Disease =|= Pharmaceutical Business Review


Description

commences trial of stem cells in coronary artery disease

Preview

Tags

Users

  • @avivagabriel

Comments and Reviews